Navigation Links
24th Annual EAU Congress highlights many new developments

The 24th Annual Congress of the European Association of Urology (EAU) will be held from 17 to 21 March 2009 in the Stockholm International Fairs (SE). The EAU aims to present the best of scientific results, lectures and educational courses; the scientific programme covers the whole range of the urological field. Chairman of the EAU Scientific Congress Office Professor Freddie Hamdy has identified several scientific highlights.

In Stockholm the EAU expects to welcome an estimated 10,000 delegates and 3,000 exhibitors.

According to Professor Hamdy highlights include, among other things, the State-of-the-art lecture 'Watchful waiting versus radical prostatectomy - an updated from the SPCG-4 trial' by Professor Lars Holmberg from Uppsala (SE), held from 8:15 to 8:35 hours on Friday, 20 March. "In 2005 the researchers reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. Now results after 3 more years of follow-up are reported", he says.

The lecture 'The PCA3 test in the diagnosis of prostate cancer' by Dr. Monique Roobol from Rotterdam (NL) Friday 20 March from 9:20 to 9:35 hours gives an overview of the value of the Prostate Cancer Antigen 3 (PCA3) test for clinical applications based on the available literature and new data. The serum PSA value is the most commonly used marker in the detection and monitoring of prostate cancer, but prostate cancer is present throughout the entire PSA spectrum; this was confirmed by the biopsy results in men randomised to the control arm of the Prostate Cancer Prevention Trial (PCPT). Developments in molecular biology techniques have led to the identification of numerous genes and proteins that are believed to be relevant for the development of prostate cancer. This has resulted in a commercially available gene-based test, the PCA3 test.

On the same day, from 10:05 to 10:25 hours, Dr. Martin Gleave will give the Socit Internationale d'Urologie lecture 'Castration resistant prostate cancer: New therapeutic approaches'. Advanced prostate cancer has high initial response rates to androgen ablation. However, remissions are temporary because surviving tumour cells usually progress to castrate-refractory prostate cancer. Dr. Gleave will be discussing the status of several novel agents in clinical trials either as single agents or in combination with cytotoxic chemotherapy, including the androgen receptor, endothelin receptor, and molecular chaperones.

Dr. Smith from Boston (U.S.) is keen on presenting the exciting results of his trial (A randomized, double-blind, placebo-controlled trial of denosumab in men receiving androgen deprivation therapy for non-metastatic prostate cancer) from 10:25 to 10:55 hours as part of the 'The best EAU papers' session.

According to Dr. Johann de Bono from London (UK), who will be presenting 'New approaches to target androgen receptors in prostate cancer' from 11:45 to 12:00 hours, there is now incontrovertible evidence that what we have previously defined as hormone refractory prostate cancer is a disease that remains steroid hormone drive. Clinical evidence is now available that novel agents targeting androgen synthesis and more potent androgen receptor antagonists have significant antitumor activity. He will be reporting about trials with these novel agents.

On Saturday, 21 March, Professor Fritz Schrder from Rotterdam (NL) will be giving an important update on the European Randomised Study of Screening for Prostate Cancer (ERSPC) from 11:15 to 11:35 hours. The ERSPC is a large European study involving 8 countries (Belgium, Finland, France, Italy, Sweden, Spain, Switzerland and the Netherlands). This presentation will, for the first time, summarise results obtained by all centres.

More information about the new initiative 'EAU TV', the Meet-the-Expert sessions and the EAU Press Conference which will be opened by Swedish TV host and producer Mr Hasse Aro - will follow shortly.


Contact: Lindy Brouwer
European Association of Urology

Related medicine news :

1. Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party
2. AUA Annual Scientific Meeting features more new research than ever before
3. Healthy Humor & Laughter are in the Cards at the 22nd Annual Association for Applied and Therapeutic Humor Conference
4. GBC Seeks Nominations for Fourth Annual Bioscience Awards
5. Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C.
6. Cadient Interactives Will Reese to Discuss Strategies for Engaging Physicians Online at Eighth Annual ePharma Summit
7. Align Technology Executives to Present at ROTH 21st Annual OC Growth Stock Conference
8. Elder Abuse Prevention the Focus of Wayne County Medical Society Foundations Annual Chinese New Year Fundraiser
9. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
10. Michigan Dentists Giving Free Dental Care to Low-Income Children During Annual Give Kids a Smile Program Starting February 6
11. Sunstar to Support ADAs 60th Annual National Childrens Dental Health Month
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology: